Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
547.51B
Market cap547.51B
Price-Earnings ratio
20.64
Price-Earnings ratio20.64
Dividend yield
2.26%
Dividend yield2.26%
Average volume
10.11M
Average volume10.11M
High today
$229.98
High today$229.98
Low today
$227.00
Low today$227.00
Open price
$228.67
Open price$228.67
Volume
9.64M
Volume9.64M
52 Week high
$229.98
52 Week high$229.98
52 Week low
$141.50
52 Week low$141.50

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $227.32. The company's market cap stands at 547.51B, with a P/E ratio of 20.64 and a dividend yield of 2.3%.

On 2026-01-29, Johnson & Johnson(JNJ) stock traded between a low of $227.00 and a high of $229.98. Shares are currently priced at $227.32, which is +0.1% above the low and -1.2% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 9.64M, against a daily average of 10.11M.

During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $229.98 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $229.98 at its peak.

JNJ News

Nasdaq 10h
March 13th Options Now Available For Johnson & Johnson

Investors in Johnson & Johnson (Symbol: JNJ) saw new options become available today, for the March 13th expiration. At Stock Options Channel , our YieldBoost fo...

March 13th Options Now Available For Johnson & Johnson
TipRanks 15h
Johnson & Johnson CEO Dumps $22M in Stock Post Q4 Results. Should Investors Worry?

Johnson & Johnson (JNJ) CEO Joaquin Duato has sold a major block of company stock just days after the healthcare giant reported mixed fourth-quarter results. Ac...

Simply Wall St 16h
Johnson & Johnson Highlights Cancer Drug Expansion And Robotic Surgery Push

Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in a new combination therapy for newly diagnosed multiple myeloma patients who are inelig...

Johnson & Johnson Highlights Cancer Drug Expansion And Robotic Surgery Push

Analyst ratings

57%

of 28 ratings
Buy
57.1%
Hold
35.7%
Sell
7.1%

More JNJ News

TipRanks 1d
Top Johnson & Johnson Insider Makes a Blockbuster Move With Company Stock

New insider activity at Johnson & Johnson ( (JNJ) ) has taken place on January 28, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and powerfu...

Investing.com 1d
Duato, Johnson & Johnson CEO, sells $22.1 million in JNJ stock - Investing.com

...

Duato, Johnson & Johnson CEO, sells $22.1 million in JNJ stock - Investing.com
Nasdaq 1d
Dividend Growers: 2 Stocks That Could Be Worth $1 Trillion in 7 Years

Key Points Visa's terrific business should help support its dividend program. Johnson & Johnson has over 50 years of consecutive dividend growth. 10 stocks w...

Dividend Growers: 2 Stocks That Could Be Worth $1 Trillion in 7 Years
TipRanks 2d
Johnson & Johnson upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley upgraded Johnson & Johnson to Overweight from Equal Weight with a price target of $262, up from $200. The firm cites its higher estimates from th...

TipRanks 2d
J&J confirms FDA approves quadruplet regimen for multiple myeloma

Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration approved Darzalex Faspro in combination with bortezomib, lenalidomide and dex...

Nasdaq 2d
Dow Analyst Moves: JNJ

The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnso...

Dow Analyst Moves: JNJ
Nasdaq 3d
Johnson & Johnson a Top Ranked SAFE Dividend Stock With 2.4% Yield

Johnson & Johnson (Symbol: JNJ) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-averagestatistics including a strong...

Johnson & Johnson a Top Ranked SAFE Dividend Stock With 2.4% Yield

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.